Zach Kass, who worked on OpenAI's go-to-market strategy, explains why AI might not be the cancer cure everyone expects. The gap between what AI can do in the lab and what actually saves patients is wider than most people think.
And I heard a great presentation about a year and a half ago from Zach Kass, who's now kind of a futurist and AI speaker. But he was very one of the early employees and one of the leaders in the go to market strategy at OpenAI and or and or ChatGPT. You know, he shared that. He said, you know, it's almost impossible that I won't solve cancer and other health issues just because every day we get new data sources of, you know, Mr. Mueller, who is fighting this type of cancer, is having this result. We have these new inputs every day. We have mortality rates and all of the things that happen with that. And these models are going to just learn and learn and learn and extrapolate and grow that will find those answers to those things. The problem is we can't power the AI properly.
What does AI actually mean for a wholesale distributor #WholesaleDistribution
If your systems don’t talk to each other, your AI won’t either #AITransformation
This is why one AI agent isn’t enough for high-stakes decisions #WholesaleDistribution
